Resgreen Group Announces Completion of Demonstration Facility for PullBuddy, Light Load Transport Vehicles, and Botway Express
SHELBY TOWNSHIP, MI / ACCESSWIRE / November 17, 2021 / Resgreen Group International (OTC PINK:RGGI),…
SHELBY TOWNSHIP, MI / ACCESSWIRE / November 17, 2021 / Resgreen Group International (OTC PINK:RGGI),…
STOCKHOLM, SWEDEN / ACCESSWIRE / November 17, 2021 / Hilbert Group (STO:HILB-B) Hilbert Group AB…
LAS VEGAS, NV / ACCESSWIRE / November 17, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF)…
VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) (“NeonMind” or…
Expansion and Infill Drilling Increases and Upgrades the Mineral Resources THUNDER BAY, ON / ACCESSWIRE…
The 2021 beneficiaries were selected from a pool of over 400,000 applications, based on their…
LAS VEGAS, NV / ACCESSWIRE / November 17, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH),…
Collaboration to Spur Global Adoption of 6 GHz Wi-Fi & Enable Better User Experience Indoors…
November 17, 2021 Nomination Committee appointed for the Annual General Meeting 2022 in LIDDS UPPSALA,…
PRESS RELEASE November 17, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally…
Press Release Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe Newly…
Clinical trial sponsored and conducted by the Italian Oncology Foundation FoRT and supported by Bristol…
New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. Avelumab (BAVENCIO®)…
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, and Rockville, MD, USA, November 17,…
Oslo (Norway), 17 November 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
WATERTOWN, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
WATERTOWN, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Atea to lead global clinical trial development of AT-527 and regain ex-US commercial rights BOSTON,…
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…